ECSP10010471A - Agonistas nicotínicos alfa 7 y antipsicóticos - Google Patents

Agonistas nicotínicos alfa 7 y antipsicóticos

Info

Publication number
ECSP10010471A
ECSP10010471A EC2010010471A ECSP10010471A ECSP10010471A EC SP10010471 A ECSP10010471 A EC SP10010471A EC 2010010471 A EC2010010471 A EC 2010010471A EC SP10010471 A ECSP10010471 A EC SP10010471A EC SP10010471 A ECSP10010471 A EC SP10010471A
Authority
EC
Ecuador
Prior art keywords
antipsychotic
alfa
nicotine agonists
nicotine
agonists
Prior art date
Application number
EC2010010471A
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Kristen G Jordan
Sharon R Letchworth
Terry Hauser
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of ECSP10010471A publication Critical patent/ECSP10010471A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

La presente Invención se relaciona con una combinación sinérgica de un agonista nicotínico alfa 7 (?7) y un agente antipsicótico.
EC2010010471A 2008-02-13 2010-09-09 Agonistas nicotínicos alfa 7 y antipsicóticos ECSP10010471A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13

Publications (1)

Publication Number Publication Date
ECSP10010471A true ECSP10010471A (es) 2010-10-30

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010471A ECSP10010471A (es) 2008-02-13 2010-09-09 Agonistas nicotínicos alfa 7 y antipsicóticos

Country Status (26)

Country Link
US (1) US20110059947A1 (es)
EP (2) EP2254598B1 (es)
JP (1) JP2011511845A (es)
KR (1) KR20100113163A (es)
CN (2) CN101977628A (es)
AU (1) AU2009214625A1 (es)
BR (1) BRPI0907570A2 (es)
CA (1) CA2715268A1 (es)
CO (1) CO6290706A2 (es)
CY (1) CY1114492T1 (es)
DK (1) DK2254598T3 (es)
EC (1) ECSP10010471A (es)
ES (1) ES2430622T3 (es)
HK (1) HK1147954A1 (es)
HR (1) HRP20130749T1 (es)
IL (1) IL207389A0 (es)
MX (1) MX2010008875A (es)
NZ (1) NZ587312A (es)
PL (1) PL2254598T3 (es)
PT (1) PT2254598E (es)
RS (1) RS52941B (es)
RU (1) RU2481123C2 (es)
SG (1) SG188144A1 (es)
SI (1) SI2254598T1 (es)
WO (1) WO2009102962A2 (es)
ZA (1) ZA201005999B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
PE20131394A1 (es) 2010-09-23 2014-01-11 Abbvie Inc Monohidrato de derivados de aza-adamantano
BR112013018296A2 (pt) * 2011-01-18 2016-11-16 Targacept Inc tratamento de disfunções cognitivas em esquizofrenia
US9139576B2 (en) 2011-05-03 2015-09-22 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
CN104837820A (zh) * 2012-10-02 2015-08-12 大日本住友制药株式会社 咪唑衍生物
BR112019012573A2 (pt) 2016-12-20 2019-11-19 Lts Lohmann Therapie Systeme Ag sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템
CN117480169A (zh) * 2021-01-08 2024-01-30 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) * 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
CA2333951C (en) 1998-06-01 2012-02-28 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
KR100772854B1 (ko) * 1999-12-10 2007-11-02 와이어쓰 (Ｓ)-2-(벤질아미노-메틸)-2,3,8,9-테트라하이드로-7Ｈ-1,4-디옥시노[2,3-ｅ]인돌-8-온 및 항정신병 제제의 배합물
ES2213703T5 (es) * 2000-06-27 2011-11-02 Laboratorios S.A.L.V.A.T., S.A. Carbamatos derivados de arilalquilaminas.
US6492386B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
AU2001282874A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
EP1311505A2 (en) 2000-08-21 2003-05-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
PL362989A1 (en) 2000-12-22 2004-11-15 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
US6894042B2 (en) * 2002-02-19 2005-05-17 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
MXPA05005943A (es) * 2002-12-06 2005-08-18 Pharmacia & Upjohn Co Llc Sales fumarato cristalinas de furo[2,3-c]piridinilcarboxamida sustituida con 1-azabiciclo[2.2.2]octilo y composiciones y preparaciones de las mismas.
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
MXPA06007213A (es) * 2003-12-23 2006-08-18 Pfizer Prod Inc Combinacion terapeutica para la mejora de la cognicion y trastornos sicoticos.
JP2008533142A (ja) * 2005-03-18 2008-08-21 アボット・ラボラトリーズ α７ニューロンニコチン性受容体リガンドおよび抗精神病薬組成物

Also Published As

Publication number Publication date
ZA201005999B (en) 2011-05-25
CA2715268A1 (en) 2009-08-20
CN103143023A (zh) 2013-06-12
EP2254598A2 (en) 2010-12-01
HRP20130749T1 (en) 2013-10-11
NZ587312A (en) 2011-12-22
CN101977628A (zh) 2011-02-16
KR20100113163A (ko) 2010-10-20
BRPI0907570A2 (pt) 2019-09-24
ES2430622T3 (es) 2013-11-21
DK2254598T3 (da) 2013-07-29
EP2633868A1 (en) 2013-09-04
JP2011511845A (ja) 2011-04-14
WO2009102962A2 (en) 2009-08-20
US20110059947A1 (en) 2011-03-10
WO2009102962A3 (en) 2009-10-08
SI2254598T1 (sl) 2013-10-30
PL2254598T3 (pl) 2013-12-31
EP2254598B1 (en) 2013-07-10
CO6290706A2 (es) 2011-06-20
RU2481123C2 (ru) 2013-05-10
PT2254598E (pt) 2013-10-16
SG188144A1 (en) 2013-03-28
AU2009214625A1 (en) 2009-08-20
CY1114492T1 (el) 2016-10-05
RS52941B (en) 2014-02-28
RU2010137787A (ru) 2012-03-20
HK1147954A1 (en) 2011-08-26
IL207389A0 (en) 2010-12-30
MX2010008875A (es) 2010-08-31

Similar Documents

Publication Publication Date Title
ECSP10010471A (es) Agonistas nicotínicos alfa 7 y antipsicóticos
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CL2010001428A1 (es) Compuestos derivados de amidas y tioamidas heteroaromaticas; agente que contiene al menos uno de dichos compuestos; procedimiento para combatir parasitos; y uso de dichos compuestos.
DOP2011000104A (es) Combinacion de una insulina y un agonista de glp-1
UY33397A (es) Forma sólida de un naftaleno carboxamida
MX2013007236A (es) Composiciones fluidas que comprenden un agente de estructuracion.
GT200800123A (es) Compuestos mimeticos de lisina modificados
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MY155317A (en) Benzene sulfonamide thiazole and oxazole compounds
DOP2010000225A (es) Arilpirrolinas insecticidas
BR112012003705A2 (pt) composição lubrificante contendo um agente antidesgaste
HN2008000278A (es) Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta y su aplicacion terapeutica
RS53586B1 (en) DERIVATION OF DECISION
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI0915373A2 (pt) composições de agente de branqueamento fluorescente
AR059444A1 (es) Composiciones ramnolipidicas y metodos de uso relacionados
MA37650A1 (fr) Forme amorphe d'un composé pyrimidinyl-cyclopentane inhibiteur de akt, compositions et procédés de celle-ci
BR112012003702A2 (pt) composição lubrificante contendo um agente antidesgaste
AR067813A1 (es) Fenilendiaminas sustituidas como inhibidores de l ainteraccion entre mdm2 y p53
CR20150275A (es) Composición de difenidol de liberación prolongada
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
BR112012003694A2 (pt) composição lubrificante contendo um agente antidesgaste
UY32197A (es) Sinergismo antibiotico